Показать сокращенную информацию

dc.contributor.author Segeda, I. en
dc.contributor.author Shevchuk, S. en
dc.contributor.author Kuvikova, I. en
dc.contributor.author Shevchuk, O. en
dc.date.accessioned 2020-02-11T11:17:42Z
dc.date.available 2020-02-11T11:17:42Z
dc.date.issued 2017
dc.identifier.citation Cobalamin (Vitamin B12) status in patients with antiphospholipid syndrome (APS), its association with atherosclerotic vascular lesions / I. Segeda, S. Shevchuk, I. Kuvikova, O. Shevchuk // Ann. Rheum. Dis. – 2017. – Vol. 76, issue suppl. 2. – P. 1228-1229. en
dc.identifier.uri https://dspace.vnmu.edu.ua/123456789/4347
dc.description.abstract To evaluate vitamin B12 status in patients with antiphospholipid syndrome (APS) and to explore its relationship with atherosclerotic vascular lesion 82 patients with APS and 37 healthy individuals were observed. Content of cobalamin (vitamin B12) in serum were determined by immunochemical detection (ECLIA). It was founded that in patients with APS low cobalamin status is associated with subclinical manifestations of atherosclerotic vascular lesions. en
dc.language.iso en en
dc.subject Cobalamin (Vitamin B12) en
dc.subject antiphospholipid syndrome en
dc.subject atherosclerotic vascular lesions en
dc.subject immunochemical detection en
dc.title Cobalamin (Vitamin B12) status in patients with antiphospholipid syndrome (APS), its association with atherosclerotic vascular lesions en
dc.type Thesis en


Файлы в этом документе

Данный элемент включен в следующие коллекции

Показать сокращенную информацию